Free Trial

AMERISAFE (AMSF) to Release Earnings on Wednesday

AMERISAFE logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • AMERISAFE to report Q1 2026 results after the market closes Wednesday, April 22 (earnings call 4:30 PM ET); analysts expect $0.52 EPS and about $90.49 million in revenue.
  • Last quarter AMERISAFE missed EPS ($0.51 reported vs. $0.57 consensus), yet analysts still forecast roughly $2.00 EPS for the current and next fiscal year and the consensus rating is Hold with an average target of $45.33.
  • Dividend yield is 4.9% (quarterly $0.41, annualized $1.64) with a 66.4% payout ratio; shares trade near $33.69 with a market cap of about $633M and a P/E of ~13.6.
  • Five stocks to consider instead of AMERISAFE.

AMERISAFE (NASDAQ:AMSF - Get Free Report) is expected to be posting its Q1 2026 results after the market closes on Wednesday, April 22nd. Analysts expect AMERISAFE to post earnings of $0.52 per share and revenue of $90.4870 million for the quarter. Individuals are encouraged to explore the company's upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Wednesday, April 22, 2026 at 4:30 PM ET.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last announced its earnings results on Wednesday, February 25th. The insurance provider reported $0.51 earnings per share for the quarter, missing analysts' consensus estimates of $0.57 by ($0.06). The company had revenue of $81.59 million for the quarter, compared to the consensus estimate of $80.05 million. AMERISAFE had a net margin of 14.86% and a return on equity of 15.89%. On average, analysts expect AMERISAFE to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

AMERISAFE Trading Up 0.2%

Shares of AMSF opened at $33.69 on Wednesday. The firm's 50-day moving average price is $34.85 and its 200-day moving average price is $38.00. The firm has a market capitalization of $633.37 million, a price-to-earnings ratio of 13.64 and a beta of 0.31. AMERISAFE has a 1-year low of $32.00 and a 1-year high of $50.07.

AMERISAFE Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Friday, March 13th were paid a dividend of $0.41 per share. The ex-dividend date of this dividend was Friday, March 13th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 4.9%. AMERISAFE's payout ratio is presently 66.40%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Quarry LP raised its holdings in AMERISAFE by 346.9% in the third quarter. Quarry LP now owns 943 shares of the insurance provider's stock worth $41,000 after buying an additional 732 shares during the last quarter. Kemnay Advisory Services Inc. purchased a new position in AMERISAFE in the fourth quarter worth about $54,000. Tower Research Capital LLC TRC raised its holdings in shares of AMERISAFE by 87.9% during the second quarter. Tower Research Capital LLC TRC now owns 1,920 shares of the insurance provider's stock valued at $84,000 after purchasing an additional 898 shares during the last quarter. BNP Paribas Financial Markets raised its holdings in shares of AMERISAFE by 116.9% during the second quarter. BNP Paribas Financial Markets now owns 2,713 shares of the insurance provider's stock valued at $119,000 after purchasing an additional 1,462 shares during the last quarter. Finally, iSAM Funds UK Ltd purchased a new position in shares of AMERISAFE during the third quarter valued at approximately $152,000. 97.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Wall Street Zen lowered shares of AMERISAFE from a "hold" rating to a "sell" rating in a research note on Saturday, February 28th. Citigroup reissued a "market outperform" rating on shares of AMERISAFE in a research note on Friday, January 16th. Truist Financial dropped their price objective on shares of AMERISAFE from $45.00 to $36.00 and set a "hold" rating on the stock in a research note on Friday, February 27th. Citizens Jmp dropped their price objective on shares of AMERISAFE from $50.00 to $45.00 and set a "market outperform" rating on the stock in a research note on Monday. Finally, Weiss Ratings lowered shares of AMERISAFE from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, March 2nd. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, AMERISAFE currently has a consensus rating of "Hold" and an average target price of $45.33.

Get Our Latest Analysis on AMERISAFE

AMERISAFE Company Profile

(Get Free Report)

Amerisafe, Inc NASDAQ: AMSF is a specialty provider of workers' compensation insurance products and services in the United States. The company focuses on underwriting and managing workers' compensation policies for small to mid-sized public and private businesses, particularly in higher-hazard industries such as retail, manufacturing, distribution and wholesale. Through its network of independent agents, Amerisafe delivers tailored coverage solutions that combine robust risk management support with loss prevention programs designed to enhance workplace safety.

In addition to core insurance offerings, Amerisafe provides extensive risk control resources, including safety training, on-site consultations and claims management services.

Recommended Stories

Earnings History for AMERISAFE (NASDAQ:AMSF)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AMERISAFE Right Now?

Before you consider AMERISAFE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.

While AMERISAFE currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines